Publications by authors named "Gary Raskob"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

62

Total Likes

256

Extended Reach

1,682,002

Social Features

158
E
Efficacy and safety of REGN9933 and REGN7508 for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials.
Jeffrey I Weitz, Aaron P Kithcart, Meagan P O'Brien, Oren Levy, Ethan Marin, Gary E Raskob

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study.
Vincent R Lanting, Kika van Bergen En Henegouwen, Floris T M Bosch, Michael A Grosso, Annelise Segers, Gary E Raskob

J Thromb Haemost· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction Model.
Vincent R Lanting, Toshihiko Takada, Floris T M Bosch, Andrea Marshall, Michael A Grosso, Gary E Raskob

Thromb Haemost· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer.
Rushad Patell, Charles Hsu, Minggao Shi, Michael A Grosso, Anil Duggal, Gary Raskob

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
Tzu-Fei Wang, Alok A Khorana, Giancarlo Agnelli, Dan Bloomfield, Marc P Bonaca, Gary E Raskob

Oncologist· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant Therapy for Mechanical Heart Valves - Unmet Need Persists.
Gary E Raskob

NEJM Evid· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
Maria A de Winter, Harry R Büller, Marc Carrier, Alexander T Cohen, John-Bjarne Hansen, Gary E Raskob

Eur Heart J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis.
Maria A de Winter, Alicia Uijl, Harry R Büller, Marc Carrier, Alexander T Cohen, Gary E Raskob

J Thromb Haemost· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population.
Gary E Raskob, Aaron M Wendelboe, Janis Campbell, Lance Ford, Kai Ding

J Thromb Haemost· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
Gary E Raskob, Walter Ageno, Gregory Albers, C Gregory Elliott, Jonathan Halperin

J Am Heart Assoc· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study.
Alex C Spyropoulos, Gary E Raskob, Theodore E Spiro, Wentao Lu, Yoriko De Sanctis

TH Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial.
Alex C Spyropoulos, Mark Goldin, Walter Ageno, Gregory W Albers, C Gregory Elliott, Gary E Raskob

TH Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
Alex C Spyropoulos, Gary E Raskob, Alexander T Cohen, Walter Ageno, Jeffrey I Weitz

Circulation· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Applicability of Using Natural Language Processing to Support Nationwide Venous Thromboembolism Surveillance: Model Evaluation Study.
Aaron Wendelboe, Ibrahim Saber, Justin Dvorak, Alys Adamski, Natalie Feland, Gary Raskob

JMIR Bioinform Biotechnol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
Concetta Lipardi, C Gregory Elliott, Chiara L Sugarmann, Lloyd Haskell, Alex C Spyropoulos, Gary E Raskob

Clin Appl Thromb Hemost· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
Floris T M Bosch, Frits I Mulder, Menno V Huisman, Jeffrey I Zwicker, Marcello Di Nisio, Gary E Raskob

J Thromb Haemost· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milvexian for the Prevention of Venous Thromboembolism.
Jeffrey I Weitz, John Strony, Walter Ageno, David Gailani, Elaine M Hylek, Gary E Raskob

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
Walter Ageno, Renato D Lopes, Mark Goldin, Roger D Yusen, Gregory W Albers, Gary E Raskob

J Thromb Haemost· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S Wells, Clive Kearon, Gary E Raskob

J Thromb Haemost· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abelacimab for Prevention of Venous Thromboembolism. Reply.
Jeffrey I Weitz, Gary E Raskob, B Alexander Yi

N Engl J Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
Gary E Raskob, Alex C Spyropoulos, Theodore E Spiro, Wentao Lu, Zhong Yuan

J Am Heart Assoc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S Wells, Clive Kearon, Gary E Raskob

Ann Intern Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
Aaron M Wendelboe, Janis Campbell, Kai Ding, Dale W Bratzler, Michele G Beckman, Gary E Raskob

Thromb Haemost· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
Gary E Raskob, Alex C Spyropoulos, Alexander T Cohen, Jeffrey I Weitz, Walter Ageno

J Am Heart Assoc· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis